litlas
ログインアカウント作成

J. Carl Barrett

1966–2025 年に発表

236
論文数
59,117
被引用数
124
h 指数
231
i10 指数

被引用数

J. Carl Barrett の年別被引用数1967 年: 被引用 2 件1968 年: 被引用 6 件1969 年: 被引用 3 件1970 年: 被引用 5 件1971 年: 被引用 8 件1972 年: 被引用 4 件1973 年: 被引用 6 件1974 年: 被引用 3 件1975 年: 被引用 5 件1976 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 6 件1980 年: 被引用 11 件1981 年: 被引用 9 件1982 年: 被引用 11 件1983 年: 被引用 14 件1984 年: 被引用 10 件1985 年: 被引用 28 件1986 年: 被引用 24 件1987 年: 被引用 11 件1988 年: 被引用 15 件1989 年: 被引用 41 件1990 年: 被引用 33 件1991 年: 被引用 28 件1992 年: 被引用 29 件1993 年: 被引用 68 件1994 年: 被引用 65 件1995 年: 被引用 168 件1996 年: 被引用 221 件1997 年: 被引用 295 件1998 年: 被引用 258 件1999 年: 被引用 319 件2000 年: 被引用 379 件2001 年: 被引用 334 件2002 年: 被引用 361 件2003 年: 被引用 364 件2004 年: 被引用 429 件2005 年: 被引用 579 件2006 年: 被引用 598 件2007 年: 被引用 570 件2008 年: 被引用 602 件2009 年: 被引用 517 件2010 年: 被引用 506 件2011 年: 被引用 446 件2012 年: 被引用 423 件2013 年: 被引用 451 件2014 年: 被引用 368 件2015 年: 被引用 381 件2016 年: 被引用 489 件2017 年: 被引用 483 件2018 年: 被引用 461 件2019 年: 被引用 1,477 件2020 年: 被引用 1,595 件2021 年: 被引用 1,486 件2022 年: 被引用 1,144 件2023 年: 被引用 855 件2024 年: 被引用 1,328 件2025 年: 被引用 773 件2026 年: 被引用 12 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,786 件、この内訳の 30.7%中国: 引用元論文 2,230 件、この内訳の 8.8%イギリス: 引用元論文 1,810 件、この内訳の 7.1%ドイツ: 引用元論文 1,195 件、この内訳の 4.7%イタリア: 引用元論文 1,167 件、この内訳の 4.6%フランス: 引用元論文 974 件、この内訳の 3.8%日本: 引用元論文 906 件、この内訳の 3.6%カナダ: 引用元論文 905 件、この内訳の 3.6%スペイン: 引用元論文 794 件、この内訳の 3.1%オーストラリア: 引用元論文 678 件、この内訳の 2.7%オランダ: 引用元論文 627 件、この内訳の 2.5%韓国: 引用元論文 498 件、この内訳の 2%
0%30.7%その他 22.8%

機関

分野

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology41.6%
  • Immunology and Microbiology2%
  • Environmental Science1.6%
  • Computer Science1.4%
  • Chemistry1.3%
  • その他4.6%

トピック

  • Cancer Genomics and Diagnostics4.6%
  • DNA Repair Mechanisms3.2%
  • Genetic factors in colorectal cancer3.1%
  • Lung Cancer Treatments and Mutations3.1%
  • BRCA gene mutations in cancer2.7%
  • PARP inhibition in cancer therapy2.6%
  • その他80.7%

共著者

全論文

検索で開く
  1. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

    著者: Christopher Abbosh, Alexander M. Frankell, Thomas Harrison, Judit Kisistók, Aaron T. Garnett, Laura Johnson, Selvaraju Veeriah, Mike Moreau, Adrian Chesh, Tafadzwa L. Chaunzwa, Jakob Weiss, Morgan R. Schroeder, Sophia Ward, Kristiana Grigoriadis, Aamir Shahpurwalla, Kevin Litchfield, Clare Puttick, Dhruva Biswas, Takahiro Karasaki, James R. Black, Carlos Martínez‐Ruiz, Maise Al Bakir, Oriol Pich, Thomas B.K. Watkins, Emilia L. Lim, Ariana Huebner, David A. Moore, Nadia Godin-Heymann, Anne L’Hernault, Hannah Bye, Aaron Odell, Paula Kalavakur, Fábio Gomes, Akshay J. Patel, Elizabeth Manzano, Crispin T. Hiley, Nicolas Carey, Joan Riley, Daniel E. Cook, Darren Hodgson, Daniel Stetson, J. Carl Barrett, Roderik M. Kortlever, Gérard I. Evan, Allan Hackshaw, Robert Daber, Jacqui Shaw, Hugo J.W.L. Aerts, Abel Licon, Josh Stahl, Mariam Jamal‐Hanjani, J.F. Lester, Amrita Bajaj, Apostolos Nakas, Azmina Sodha-Ramdeen, Keng Ang, Mohamad Tufail, Mohammed Fiyaz Chowdhry, Molly Scotland, Rebecca Boyles, Sridhar Rathinam, Claire Wilson, Domenic Marrone, Sean Dulloo, Dean A. Fennell, Gurdeep Matharu, Lindsay Primrose, Ekaterini Boleti, Heather Cheyne, Mohammed S. Khalil, Shirley Richardson, Tracey Cruickshank, Gillian Price, Keith M. Kerr, Sarah Benafif, Kayleigh Gilbert, Babu Naidu, Aya Osman, Christer Lacson, Gerald Langman, Helen Shackleford, Madava Djearaman, Salma Kadiri, Gary Middleton, Angela Leek, Jack Davies Hodgkinson, Nicola Totten, Ángeles Montero, Elaine Smith, Eustace Fontaine, Felice Granato, Helen Doran, Juliette Novasio, Kendadai Rammohan, Leena Dennis Joseph, Paul Bishop, Rajesh Shah, Stuart Moss, Vijay Joshi, Philip Crosbie ほか 206 名 - Nature 2023 被引用: 343

  2. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

    著者: Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard - Nature Medicine 2015 被引用: 1,539

  3. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

    著者: Zhongwu Lai, Aleksandra Markovets, Miika Ahdesmäki, Brad Chapman, Oliver Hofmann, Robert McEwen, Justin Johnson, Brian Dougherty, J. Carl Barrett, Jonathan R. Dry - Nucleic Acids Research 2016 被引用: 1,075

  4. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

    著者: Juliann Chmielecki, Jhanelle E. Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng‐Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J. Carl Barrett, Ryan J. Hartmaier, Suresh S. Ramalingam - Nature Communications 2023 被引用: 239

  5. Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

    著者: Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu, Shaad E. Abdullah, Brandon W. Higgs, Phillip A. Dennis, Michiel S. van der Heijden, Neil H. Segal, Jamie E. Chaft, Todd Hembrough, J. Carl Barrett, Matthew D. Hellmann - Cancer Discovery 2020 被引用: 336

  6. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

    著者: Diana M. Merino, Lisa M. McShane, David Fabrizio, Vincent Funari, Shu‐Jen Chen, James R. White, Paul Wenz, Jonathan Baden, J. Carl Barrett, Ruchi Chaudhary, Li Chen, Wangjuh Chen, Jen‐Hao Cheng, Dinesh Cyanam, Jennifer S. Dickey, Vikas Gupta, Matthew D. Hellmann, Elena Helman, Yali Li, Joerg Maas, Arnaud Papin, Rajesh Patidar, Katie Quinn, Naiyer A. Rizvi, Hongseok Tae, Christine K. Ward, Mingchao Xie, Ahmet Zehir, Chen Zhao, Manfred Dietel, Albrecht Stenzinger, Mark Stewart, Jeff Allen - Journal for ImmunoTherapy of Cancer 2020 被引用: 506

  7. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

    著者: Yoshio Miki, Jeffrey Swensen, Donna Shattuck-Eidens, P. Andrew Futreal, Keith Harshman, Sean V. Tavtigian, Qingyun Liu, Charles Cochran, L. Michelle Bennett, Wei Ding, Russell Bell, Judith Rosenthal, Charles E. Hussey, Thanh V. Tran, Melody McClure, Cheryl A. Frye, Tom Hattier, Robert Phelps, Astrid C. Haugen, Harold L. Katcher, Kazuko Yakumo, Zahra Gholami, Daniel J. Shaffer, Steven Stone, Steven R Bayer, Christian Wray, Robert Bogden, Priya Dayananth, John H. Ward, Patricia N. Tonin, Steven A. Narod, Pam K. Bristow, Frank H. Norris, Leah M. Helvering, P. Morrison, Paul R. Rosteck, Mei Lai, J. Carl Barrett, Cathryn M. Lewis, Susan L. Neuhausen, Lisa Cannon‐Albright, David E. Goldgar, Roger W. Wiseman, Alexander Kamb, Mark H. Skolnick - Science 1994 被引用: 6,116

  8. Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

    著者: Asad Umar, C. Richard Boland, Jonathan P. Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralene M. Lindor, Lawrence J. Burgart, Richard C. Hamelin, Stanley R. Hamilton, Robert A. Hiatt, Jeremy R. Jass, Annika Lindblom, Henry T. Lynch, Païvi Peltomäki, Scott D. Ramsey, Miguel A. Rodrı́guez-Bigas, Hans F. A. Vasen, Ernest T. Hawk, J. Carl Barrett, Andrew N. Freedman, Sudhir Srivastava - JNCI Journal of the National Cancer Institute 2004 被引用: 3,183

  9. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6

    著者: Raúl Mostoslavsky, Katrin F. Chua, David B. Lombard, Wendy W. Pang, Miriam R. Fischer, Lionel Gellon, Pingfang Liu, Gustavo Mostoslavsky, Sonia Franco, Michael Murphy, Kevin D. Mills, Parin Patel, Joyce T. Hsu, Andrew L. Hong, Ethan Ford, Hwei-Ling Cheng, Caitlin Kennedy, Nomelí P. Núñez, Roderick T. Bronson, David Frendewey, Wojtek Auerbach, David M. Valenzuela, Margaret Karow, Michael O. Hottiger, Stephen D. Hursting, J. Carl Barrett, Leonard Guarente, Richard Mulligan, Bruce Demple, George D. Yancopoulos, Frederick W. Alt - Cell 2006 被引用: 1,636

  10. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

    著者: Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, Michael Friedländer, Ignace Vergote, Gordon Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira‐Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Stuart Spencer, Brian Dougherty, Maria Orr, Darren Hodgson, J. Carl Barrett, Ursula A. Matulonis - The Lancet Oncology 2014 被引用: 1,443

  11. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

    著者: Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez, Alba Llop‐Guevara, Yasir H. Ibrahim, Albert Gris‐Oliver, Sandra Bonache, Beatriz Morancho, Alejandra Bruna, Oscar M. Rueda, Zhongwu Lai, Urszula M. Polanska, Gemma N. Jones, Petra Kristel, L.D. Bustos, Marta Guzmán, Olga Rodríguez, Judit Grueso, Gemma Montalban, Ginevra Caratù, Francesco M. Mancuso, Roberta Fasani, José Jimenez, William Howat, Brian Dougherty, Ana Vivancos, Paolo Nucíforo, Xavier Serres, Isabel T. Rubio, Ana Oaknin, Elaine Cadogan, J. Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Joaquı́n Arribas, Jos Jonkers, Orland Dı́ez, Mark J. O’Connor, Judith Balmañà, Violeta Serra - Annals of Oncology 2018 被引用: 427

  12. Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

    著者: Juliann Chmielecki, Tony Mok, Yi‐Long Wu, Ji‐Youn Han, Myung‐Ju Ahn, Suresh S. Ramalingam, Thomas John, Isamu Okamoto, James Chih‐Hsin Yang, Frances A. Shepherd, Krishna C. Bulusu, Gianluca Laus, Barbara Collins, J. Carl Barrett, Ryan J. Hartmaier, Vassiliki A. Papadimitrakopoulou - Nature Communications 2023 被引用: 173

  13. Evolutionarily Conserved and Nonconserved Cellular Localizations and Functions of Human SIRT Proteins

    著者: Eriko Michishita, Jean Y. Park, Jenna M. Burneskis, J. Carl Barrett, Izumi Horikawa - Molecular Biology of the Cell 2005 被引用: 1,360

  14. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

    著者: Danish Memon, Adam J. Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang H.-F. Zhang, Mohamed Reda Keddar, Divij Mathew, Kyung Jin Yoo, Jingya Qiu, Jayon Lihm, Jayalaksmi Miriyala, Jennifer L. Sauter, Jia Luo, Andrew Chow, Umesh Bhanot, Caroline G. McCarthy, Chad Vanderbilt, Cailian Liu, Mohsen Abu-Akeel, Andrew J. Plodkowski, Nicholas McGranahan, Marta Łuksza, Benjamin D. Greenbaum, Taha Merghoub, Ikbel Achour, J. Carl Barrett, Ross Stewart, Pedro Beltrão, Taylor H. Schreiber, Andy J. Minn, Martin L. Miller, Matthew D. Hellmann - Cancer Cell 2024 被引用: 178

  15. Impact of a five-dimensional framework on R&D productivity at AstraZeneca

    著者: Paul Morgan, Dean G. Brown, Simon Lennard, Mark J. Anderton, J. Carl Barrett, Ulf G. Eriksson, Mark Fidock, Bengt Hamrén, Anthony Johnson, Ruth March, James Matcham, Jerome T. Mettetal, David Nicholls, Stefan Platz, Steve Rees, Michael Snowden, Menelas N. Pangalos - Nature Reviews Drug Discovery 2018 被引用: 423

  16. The Immunoscore: Colon Cancer and Beyond

    著者: Helen K. Angell, Daniela Bruni, J. Carl Barrett, Ronald Herbst, Jérôme Galon - Clinical Cancer Research 2019 被引用: 401

  17. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

    著者: Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir H. Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles‐Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, María Vidal, Vicente Peg, Xavier Serres, Graham Dellaire, Jacques Simard, Paolo Nucíforo, Isabel T. Rubio, Rodrigo Dienstmann, J. Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J. O’Connor, Orland Dı́ez, Judith Balmañà, Violeta Serra - EMBO Molecular Medicine 2018 被引用: 274

  18. Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

    著者: Diana Merino Vega, Laura M. Yee, Lisa M. McShane, P. Mickey Williams, L. Chen, Tomas Vilimas, David Fabrizio, Vincent Funari, Justin Y. Newberg, L.K. Bruce, S.-J. Chen, Jonathan Baden, J. Carl Barrett, Philip Beer, Matthew G. Butler, Jen‐Hao Cheng, Jeffrey Conroy, Dinesh Cyanam, Kenneth R. Eyring, E. Garcia, G. Green, Vivi Raundahl Gregersen, Matthew D. Hellmann, Laurel A. Keefer, Laura Lasiter, Alexander J. Lazar, M.-C. Li, Laura E. MacConaill, Kristen Meier, Hestia Mellert, Sarabjot Pabla, Aparna Pallavajjalla, Gary A. Pestano, Roberto Salgado, Raed Samara, Ethan S. Sokol, Phillip Stafford, Jan Budczies, Albrecht Stenzinger, W Tom, Kenneth C. Valkenburg, X.Z. Wang, Victor Weigman, Mingchao Xie, Qiqi Xie, Ahmet Zehir, Chen Zhao, Yiqiang Zhao, Mark Stewart, Jeff Allen - Annals of Oncology 2021 被引用: 182

  19. Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer

    著者: Suresh S. Ramalingam, James Chih‐Hsin Yang, Chee Khoon Lee, Takayasu Kurata, Dong‐Wan Kim, Thomas John, Naoyuki Nogami, Yuichiro Ohe, Helen Mann, Yuri Rukazenkov, Serban Ghiorghiu, Daniel Stetson, Aleksandra Markovets, J. Carl Barrett, Kenneth S. Thress, Pasi A. Jänne - Journal of Clinical Oncology 2017 被引用: 536

  20. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

    著者: Benjamin Besse, Elvire Pons‐Tostivint, Keunchil Park, Sylvia Hartl, Patrick M. Forde, Maximilian J. Hochmair, Mark M. Awad, Michael Thomas, Glenwood Goss, Paul Wheatley‐Price, Frances A. Shepherd, Marie Florescu, Parneet Cheema, Quincy S. Chu, Sang‐We Kim, Daniel Morgensztern, Melissa L. Johnson, Sophie Cousin, Dong‐Wan Kim, Mor Moskovitz, David Vicente, Boaz E. Aronson, Rosalind Hobson, Helen J. Ambrose, Sajan Khosla, Avinash Reddy, Deanna L. Russell, Mohamed Reda Keddar, James Conway, J. Carl Barrett, Emma Dean, Rakesh Kumar, Marlene Dressman, Philip J. Jewsbury, Sonia Iyer, Simon T. Barry, Jan Cosaert, John V. Heymach - Nature Medicine 2024 被引用: 116

  21. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

    著者: Suresh S. Ramalingam, Yi Cheng, C. Zhou, Y. Ohe, Fumio Imamura, Byoung Chul Cho, Meng‐Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, A. Todd, Aleksandra Markovets, J. Carl Barrett, Juliann Chmielecki, Jhanelle E. Gray - Annals of Oncology 2018 被引用: 355

  22. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

    著者: Eriko Michishita, Ronald A. McCord, Elisabeth Berber, Mitomu Kioi, Hesed Padilla‐Nash, Mara Damian, Peggie Cheung, Rika Kusumoto, Tiara L.A. Kawahara, J. Carl Barrett, Howard Y. Chang, Vilhelm A. Bohr, Thomas Ried, Or Gozani, Katrin F. Chua - Nature 2008 被引用: 1,117

  23. Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

    著者: Jhanelle E. Gray, Myung‐Ju Ahn, Geoffrey R. Oxnard, Frances A. Shepherd, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng‐Chih Lin, Yi‐Long Wu, Margarita Majem, Oliver Gautschi, Michael Boyer, Krishna C. Bulusu, Aleksandra Markovets, J. Carl Barrett, Rachel Hodge, Astrid McKeown, Ryan J. Hartmaier, Juliann Chmielecki, Vassiliki A. Papadimitrakopoulou, Suresh S. Ramalingam - Clinical Cancer Research 2023 被引用: 60

  24. Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

    著者: Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden, Rachael Lawrance, Cloud P. Paweletz, Mireille Cantarini, James Chih‐Hsin Yang, J. Carl Barrett, Pasi A. Jänne - Journal of Clinical Oncology 2016 被引用: 843